YorkBridge Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.69M Sell
6,440
-1,189
-16% -$319K 0.43% 61
2022
Q3
$1.72M Buy
7,629
+1,189
+18% +$288K 0.44% 56
2022
Q2
$1.57M Hold
6,440
0.41% 58
2022
Q1
$1.56M Hold
6,440
0.34% 64
2021
Q4
$1.45M Sell
6,440
-173
-3% -$36.5K 0.32% 68
2021
Q3
$1.41M Sell
6,613
-134
-2% -$30.8K 0.35% 66
2021
Q2
$1.65M Hold
6,747
0.43% 62
2021
Q1
$1.68M Buy
6,747
+840
+14% +$200K 0.5% 55
2020
Q4
$1.36M Buy
5,907
+17
+0.3% +$3.92K 0.45% 58
2020
Q3
$1.5M Sell
5,890
-591
-9% -$146K 0.63% 49
2020
Q2
$1.53M Buy
6,481
+96
+2% +$21.9K 0.7% 45
2020
Q1
$1.29M Buy
6,385
+10
+0.2% +$2.18K 0.8% 45
2019
Q4
$1.54M Buy
6,375
+85
+1% +$18.7K 0.7% 43
2019
Q3
$1.22M Sell
6,290
-475
-7% -$91.2K 0.61% 52
2019
Q2
$1.25M Sell
6,765
-29
-0.4% -$5.19K 0.55% 49
2019
Q1
$1.29M Hold
6,794
0.6% 49
2018
Q4
$1.32M Buy
6,794
+1
+0% +$195 0.7% 44
2018
Q3
$1.41M Sell
6,793
-38
-0.6% -$7.49K 0.64% 46
2018
Q2
$1.26M Hold
6,831
0.55% 49
2018
Q1
$1.17M Hold
6,831
0.54% 52
2017
Q4
$1.19M Sell
6,831
-422
-6% -$74.7K 0.58% 46
2017
Q3
$1.35M Buy
7,253
+41
+0.6% +$7.26K 0.7% 37
2017
Q2
$1.25M Sell
7,212
-394
-5% -$64.1K 0.66% 44
2017
Q1
$1.24M Buy
7,606
+1,447
+23% +$240K 0.65% 43
2016
Q4
$896K Buy
+6,159
New +$927K 0.53% 54

Other funds holding AMGN

YorkBridge Wealth Partners's AMGN Position: Q4 2022 in Review

YorkBridge Wealth Partners reduced its Amgen (AMGN) stake by 16% in Q4 2022, selling an estimated $319K and leaving 6,440 shares worth $1.69M. The position accounts for 0.43% of the portfolio, ranked #61.

YorkBridge Wealth Partners first reported a position in AMGN in Q4 2016 and has held it in 25 quarters since. The position peaked at $1.72M in Q3 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • YorkBridge Wealth Partners held 6,440 shares of Amgen worth $1.69M as of Q4 2022.
  • YorkBridge Wealth Partners sold 1,189 Amgen shares in Q4 2022, an estimated $319K.
  • Amgen made up 0.43% of YorkBridge Wealth Partners's portfolio in Q4 2022, its #61 holding.
  • YorkBridge Wealth Partners first reported a position in Amgen in Q4 2016 and has held it in 25 quarters since.
  • YorkBridge Wealth Partners's Amgen position peaked at $1.72M in Q3 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.